Rifampicin inhibits apoptosis in rotenone-induced differentiated PC12 cells by ameliorating mitochondrial oxidative stress

Neural Regeneration Research

Volumn 5, Issue 4, 2010, Pages 251-256

  Chen, Shiwen ^a   Sun, Yuanlin ^a   Zeng, Zhifeng ^a   Tao, Enxiang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Mitochondrial dysfunction; Neural regeneration; Oxidative stress; PC12 cells; Rifampicin; Rotenone

Indexed keywords

DICHLORODIHYDROFLUORESCEIN DIACETATE; GLUTATHIONE; HOE 33342; NERVE GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; RIFAMPICIN; ROTENONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRAIN; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CHINA; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; INTRACELLULAR SPACE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL OXIDATIVE STRESS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEPLETION; RAT; REPEAT PROCEDURE;

EID: 77949369232     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2010.04.002     Document Type: Article

References (32)

1. Babić T, Mahović D. Parkinson's disease-challenges in new drug development. Coll Antropol. 2008;32(4):1275-1281.
2. Namba Y, Kawatsu K, Izumi S, et al. Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients. Lancet. 1992;340(8825):978.
3. Chui DH, Tabira T, Izumi S, et al. Decreased beta-amyloid and increased abnormal tau deposition in the brain of aged patients with leprosy. Am J Pathol. 1994;145(4):771-775.
4. Xu J, Wei C, Xu C, et al. Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an α-synuclein multimer. Brain Res. 2007;1139:220-225.
5. Oida Y, Kitaichi K, Nakayama H, et al. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain. Brain Res. 2006;1082(1):196-204.
6. Xu JY, Wang T. Inhibitory effect of rifampicin on rotenone- induced apoptosis of SH-SY5Y cells. Huazhong Keji Daxue Xuebao. 2008;37(3):329-331.
7. Tao EX, Zhang GH, Xu J, et al. Rifampicin protects rats against rotenone-induced dopaminergic neurons damage. Zhongguo Bingli Shengli Zazhi. 2008;24(9):1751-1756.
8. Tomiyama T, Shoji A, Kataoka K, et al. Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem. 1996;271(12):6839-6844.
9. Kim S, Seo JH, Suh YH. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease. Parkinsonism Relat Disord. 2004;10(Suppl 1):S9-13.
10. Kapurniotu A. Targeting alpha-synuclein in Parkinson's disease. Chem Biol. 2004;11(11):1476-1478.
11. Bradbury J. New hope for mechanism-based treatment of Parkinson's disease. Drug Discov Today. 2005;10(2):80-81.
12. Li J, Zhu M, Rajamani S. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Chem Biol. 2004;11(11):1513-1521.
13. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol. 1992;31(2):119-130.
14. Adams JD Jr, Chang ML, Klaidman L. Parkinson's disease-redox mechanisms. Curr Med Chem. 2001;8(7):809-814.
15. Grigor'ian GA, Bazian AS. The experimental models of Parkinson's disease in animals. Usp Fiziol Nauk. 2007;38(4):80-88.
16. Dhillon AS, Tarbutton GL, Levin JL, et al. Pesticide/environmental exposures and Parkinson's disease in East Texas. J Agromedicine. 2008;13(1):37-48.
17. Sai Y, Wu Q, Le W, et al. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Toxicol In Vitro. 2008;22(6):1461-1468.
18. Costa C, Belcastro V, Tozzi A, et al. Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. J Neurosci. 2008;28(32):8040-8052.
19. Starkov AA. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci. 2008;1147:37-52.
20. Tretter L, Sipos I, Adam-Vizi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem Res. 2004;29(3):569-577.
21. Westerink RH, Ewing AG. The PC12 cell as model for neurosecretion. Acta Physiol (Oxf). 2008;192(2):273-285.
22. Testa CM, Sherer TB, Greenamyre JT. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res Mol Brain Res. 2005;134(1):109-118.
23. Tatton WG, Chalmers-Redman RM, Ju WJ, et al. Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther. 2002;301(2):753-764.
24. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye methods for measuring cell growth/cell kill. J Immunol Methods. 1989;119(2):203-210.
25. Zamzami N, Maisse C, Metivier D, et al. Measurement of membrane permeability and permeability transition of mitochondria. Methods Cell Biol. 2001;65:147-158.
26. Palmeira CM, Moreno AJ, Madeira VM, et al. Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions. J Pharmacol Toxicol Methods. 1996;35(1):35-43.
27. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biol Med. 1999;27(5-6):612-616.
28. Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem. 1990;190(2):360-365.
29. Whiteman M, Halliwell B. Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics. Free Radic Res. 1997;26(1):49-56.
30. Fariss MW, Chan CB, Patel M, et al. Role of mitochondria in toxic oxidative stress. Mol Interv. 2005;5(2):94-111.
31. Böttcher T, Gerber J, Wellmer A, et al. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis. 2000;181(6):2095-2098.
32. Bennett MC. The role of alpha-synuclein in neurodegenerative diseases. Pharmacol Ther. 2005;105(3):311-331.